Capital Flow Monitor · Sponsors · CIK 2032633
Patient Square Equity Co-Invest II, L.P.
Patient Square Capital, LP, MENLO PARK, CA, 94025 · (650) 677-8100
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2024
Fit score
—
Offering
—
Sold
$61.3M
% sold
—
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-18 | D/A ·current | 506(b) | — | $61.3M | — | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
James Momtazee — Executive Officer / Promoter, Menlo Park, CA
10 other raises
- Redwood Capital Discretionary Partners, L.P. $17.7M of —
- Patient Square Therapeutics II, L.P. $0 of —
- Blackwell Capital Partners II-B, L.P. $0 of —
- Patient Square Equity Executives QP II, L.P. $0 of —
- Patient Square Puma Coinvest, L.P. $0 of —
- Patient Square Premium Coinvest, L.P. $0 of —
- Kriya Therapeutics, Inc. $320.8M of $320.8M · 100.0%
- Patient Square Equity Partners II-A, L.P. $3.11B of —
- Patient Square Equity Partners II, L.P. $3.11B of —
- Blackwell Capital Partners II, L.P. $0 of —
-
Adam Fliss — Executive Officer / Promoter, Menlo Park, CA
9 other raises
- Redwood Capital Discretionary Partners, L.P. $17.7M of —
- Patient Square Therapeutics II, L.P. $0 of —
- Blackwell Capital Partners II-B, L.P. $0 of —
- Patient Square Equity Executives QP II, L.P. $0 of —
- Patient Square Puma Coinvest, L.P. $0 of —
- Patient Square Premium Coinvest, L.P. $0 of —
- Patient Square Equity Partners II-A, L.P. $3.11B of —
- Patient Square Equity Partners II, L.P. $3.11B of —
- Blackwell Capital Partners II, L.P. $0 of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.